September 16, 2020
A shareholder behind a derivative suit against executives of CBD company CV Sciences has urged a California federal judge to keep the suit alive, pointing to another judge's ruling allowing a nearly identical case to go forward.
September 02, 2020
Executives from CBD company CV Sciences asked a California federal judge to throw out a derivative suit filed by shareholders who say the company misled them about the approval of a patent, saying the fact the patent was eventually approved means it made no misstatements.
June 15, 2020
Executives from CBD company CV Sciences are facing a shareholder derivative suit over claims they hid the fact its application for a patent on a CBD and nicotine product was denied, misleading investors who believed the company was still waiting for a decision from the U.S. Patent and Trademark Office.